Ads For Aleve, Tylenol Arthritis Lines Launch In Wake Of NSAID Warning
This article was originally published in The Tan Sheet
Executive Summary
Bayer and McNeil are taking different marketing approaches for their OTC arthritis analgesics in ads aimed at consumers concerned about NSAID safety
You may also be interested in...
Tylenol Ads Spotlight OTC NSAID Class Link To COX-2 Drugs
A current Tylenol ad campaign capitalizes on FDA's requirement that OTC non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen carry class labeling.
Tylenol Ads Spotlight OTC NSAID Class Link To COX-2 Drugs
A current Tylenol ad campaign capitalizes on FDA's requirement that OTC non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen carry class labeling.
Tylenol Ads Spotlight OTC NSAID Class Link To COX-2 Drugs
A current Tylenol ad campaign capitalizes on FDA's requirement that OTC non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen carry class labeling.